MEGAN PATRICK: Open Payments
NPI 1801419213 · GEORGETOWN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461 in 26 payments from 11 companies in 2025. Trend: 2023 $233 · 2024 $214 · 2025 $461
Food & beverage: $461
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $153 |
| Novo Nordisk Inc | 3 | $57 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Amgen Inc. | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| ABBVIE INC. | 2 | $34 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Dexcom, Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Abbott Laboratories | 1 | $20 |
Products named: FARXIGA, Ozempic, AIRSUPRA, JARDIANCE, INJECTAFER, Dexcom G6 Transmitter, SHINGRIX, LEQVIO.
Industry payments across SC — which companies pay providers there.
